Shanghai Bio-heart Biological Technology Co (HKSE:02185) Research & Development: HK$68.13 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02185 Shanghai Bio-heart Biological Technology Co Ltd HKSE:02185
28 GF Score
Price HK$2.31
! 3 Warning Signs
View Full Analysis

What is Shanghai Bio-heart Biological Technology Co Research & Development?

Shanghai Bio-heart Biological Technology Co HKSE:02185 -2.33% 28 Research & Development is HK$68.13 Mil as of Dec. 2025. GuruFocus rates HKSE:02185 with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Shanghai Bio-heart Biological Technology Co's Research & Development for the six months ended in Dec. 2025 was HK$46.17 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$68.13 Mil.

Shanghai Bio-heart Biological Technology Co  (HKSE:02185) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Shanghai Bio-heart Biological Technology Co Research & Development Related Terms

Shanghai Bio-heart Biological Technology Co Research & Development Historical Data

* Premium members only.

The historical data trend for Shanghai Bio-heart Biological Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Bio-heart Biological Technology Co Research & Development Chart

Shanghai Bio-heart Biological Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 262.32 176.25 122.22 44.10 68.37

Shanghai Bio-heart Biological Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.30 23.46 20.83 21.96 46.17
HKSE:02185
28GF Score
Shanghai Bio-heart Biological Technology Co Ltd HKSE:02185
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Bio-heart Biological Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$68.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$68.13 Mil mean?
Shanghai Bio-heart Biological Technology Co (HKSE:02185) has a Research & Development of HK$68.13 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Shanghai Bio-heart Biological Technology Co and its competitors.
Is Shanghai Bio-heart Biological Technology Co's Research & Development too high?
Shanghai Bio-heart Biological Technology Co's current Research & Development is HK$68.13 Mil. Overall, Shanghai Bio-heart Biological Technology Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Bio-heart Biological Technology Co's Research & Development compare to VRTX and REGN?
Shanghai Bio-heart Biological Technology Co's Research & Development of HK$68.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Shanghai Bio-heart Biological Technology Co and its competitors. Shanghai Bio-heart Biological Technology Co's current Research & Development is HK$68.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Bio-heart Biological Technology Co stock overvalued right now?
Shanghai Bio-heart Biological Technology Co (HKSE:02185) has a current Research & Development of HK$68.13 Mil. The current Research & Development is HK$68.13 Mil. Shanghai Bio-heart Biological Technology Co's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Shanghai Bio-heart Biological Technology Co (HKSE:02185), the current Research & Development is HK$68.13 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai Bio-heart Biological Technology Co Business Description

Address No.590 Ruiqing Road, Room 302, 3rd Floor, Building 4 & Building 6, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension. Currently, the portfolio has three product candidates in various stages of clinical development.
28GF Score

Get the complete analysis for HKSE:02185

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.31
Price